ReviveMed is an MIT spinout that created the world's most advanced AI platform and a proprietary database with the highest quality and density of metabolite data. While current methods are limited to a few hundred metabolite data points at the most, ReviveMed uses data from 10,000+ metabolites. As a result, in a fraction of the time and cost, we have discovered therapeutic assets for four diseases internally, including NASH and renal cell carcinoma, and in strategic collaboration with big pharma, with a combined therapeutic market value of >$50B.

Cambridge, MA, USA

ReviveMed

MIT is a world-class educational institution where teaching and research — with relevance to the practical world as a guiding principle — continue to be its primary purpose. MIT is independent, coeducational, and privately endowed. Its five schools and one college encompass numerous academic departments, divisions and degree-granting programs, as well as interdisciplinary centers, laboratories and programs whose work cuts across traditional departmental boundaries. Interested in applying? Visit the undergraduate or graduate admissions websites.

Find jobs at MIT startups!